HomeTELO • CVE
add
Telo Genomics Corp
Previous close
$0.13
Day range
$0.12 - $0.13
Year range
$0.10 - $0.23
Market cap
12.95M CAD
Avg Volume
8.46K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 635.80K | -23.87% |
Net income | -614.22K | 26.45% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -632.52K | 23.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.25M | 73.60% |
Total assets | 2.35M | 54.08% |
Total liabilities | 603.77K | 87.88% |
Total equity | 1.75M | — |
Shares outstanding | 100.02M | — |
Price to book | 6.25 | — |
Return on assets | -113.83% | — |
Return on capital | -178.00% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -614.22K | 26.45% |
Cash from operations | -405.79K | 40.55% |
Cash from investing | — | — |
Cash from financing | 2.33M | — |
Net change in cash | 1.92M | 381.29% |
Free cash flow | -159.75K | 63.00% |
About
Founded
2011
Headquarters
Website
Employees
8
